Loading...
British American Tobacco p.l.c.
BTAFF•PNK
Consumer Defensive
Tobacco
$45.50
$-1.19(-2.56%)
British American Tobacco p.l.c. (BTAFF) Financial Performance & Statements
Review British American Tobacco p.l.c.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-5.19%
↓ 5.19%
Operating Income Growth
117.37%
↑ 117.37%
Net Income Growth
121.35%
↑ 121.35%
Operating Cash Flow Growth
-5.50%
↓ 5.50%
Operating Margin
40.83%
↑ 40.83%
Gross Margin
76.16%
↑ 76.16%
Net Profit Margin
-52.93%
↓ 52.93%
ROE
-26.71%
↓ 26.71%
ROIC
10.67%
↑ 10.67%
British American Tobacco p.l.c. (BTAFF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for British American Tobacco p.l.c. stock.
Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $12.34B | $13.84B | $6.92B | $13.44B |
Cost of Revenue | $2.16B | $4.08B | $1.32B | $4.12B |
Gross Profit | $10.18B | $9.76B | $5.60B | $9.33B |
Gross Profit Ratio | $0.82 | $0.71 | $0.81 | $0.69 |
R&D Expenses | $168.00M | $107.00M | $107.00M | $97.00M |
SG&A Expenses | $1.38B | $3.52B | $1.23B | $3.49B |
Operating Expenses | $5.92B | $3.33B | $16.35B | $3.25B |
Total Costs & Expenses | $8.08B | $7.41B | $17.68B | $7.37B |
Interest Income | $238.00M | $101.00M | $426.00M | $85.00M |
Interest Expense | $1.80B | $1.03B | $0.00 | $903.00M |
Depreciation & Amortization | $1.62B | $383.00M | $77.00M | $480.00M |
EBITDA | $5.88B | $3.43B | $3.43B | $3.21B |
EBITDA Ratio | $1.05 | $0.49 | $0.50 | $0.49 |
Operating Income | $4.26B | $6.43B | $3.35B | $6.08B |
Operating Income Ratio | $0.35 | $0.46 | $0.48 | $0.45 |
Other Income/Expenses (Net) | $1.34B | -$17.61B | -$339.00M | -$3.42B |
Income Before Tax | $5.60B | -$22.66B | -$11.18B | $5.01B |
Income Before Tax Ratio | $0.64 | -$1.64 | -$1.62 | $0.37 |
Income Tax Expense | $1.04B | -$4.14B | $2.07B | $1.27B |
Net Income | $4.49B | -$18.35B | -$9.17B | $3.94B |
Net Income Ratio | $0.36 | -$1.33 | -$1.33 | $0.29 |
EPS | $2.01 | -$8.23 | -$4.12 | $1.77 |
Diluted EPS | $2.00 | -$8.23 | -$4.12 | $1.76 |
Weighted Avg Shares Outstanding | $2.23B | $2.23B | $2.23B | $2.23B |
Weighted Avg Shares Outstanding (Diluted) | $2.23B | $2.23B | $2.23B | $2.24B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan